{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 462249436
| IUPAC_name = ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate
| image = Metethoheptazine.svg
| image2 = Metethoheptazine-3D-balls.png
| width = 180

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 509-84-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 176888
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 154060
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = S36J5ZY2TH

<!--Chemical data-->
| C=17 | H=25 | N=1 | O=2 
| molecular_weight = 275.39 g/mol
| smiles = O=C(OCC)C2(c1ccccc1)CCCN(C)CC2C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H25NO2/c1-4-20-16(19)17(15-9-6-5-7-10-15)11-8-12-18(3)13-14(17)2/h5-7,9-10,14H,4,8,11-13H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BOSULDNQDJLKKL-UHFFFAOYSA-N
| synonyms = WY-535
}}

'''Metethoheptazine'''<ref>GB Patent 843924</ref> ('''WY-535''') is an [[opioid]] [[analgesic]] from the phenazepine family. It was invented in the 1960s.<ref>Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH. Metabolism of the Non-Narcotic Analgesic, WY-535. ''[[Biochemical Pharmacology (journal)|Biochemical Pharmacology]]''. 1965 Feb;14:121-8.</ref>

Metethoheptazine produces similar effects to other opioids, including [[analgesia]], [[sedation]], [[dizziness]] and [[nausea]].

Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.<ref>http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html</ref>  The Canadian [[Controlled Drugs and Substances Act]] specifically excludes the phenazepine opioids from control.

==References==
{{Reflist|30em}}

{{Opioidergics}}

[[Category:Synthetic opioids]]
[[Category:Azepanes]]
[[Category:Ethyl esters]]
[[Category:Mu-opioid agonists]]


{{analgesic-stub}}